Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 13.57% is in line with its 5-year average of 13.19%, around the middle of its 5-year range (8.38%–16.77%).
1.53% above its 12-month average of 13.36%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
13.57%
OPERATING MARGIN AVG TTM
13.36%
OPERATING MARGIN AVG 3Y
13.39%
OPERATING MARGIN AVG 5Y
13.19%
OPERATING MARGIN AVG 10Y
10.26%
OPERATING MARGIN AVG 15Y
10.17%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.53%
CURRENT VS 3Y AVG
+1.31%
CURRENT VS 5Y AVG
+2.91%
CURRENT VS 10Y AVG
+32.31%
CURRENT VS 15Y AVG
+33.45%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-8.93%
vs the sector median at left
IQVIA Holdings Inc.
Market Cap
$42.12B
Operating Margin
13.57%
TTM Avg
13.36%
3Y Avg
13.39%
5Y Avg
13.19%
Market Cap
$43.07B
Operating Margin
11.45%
TTM Avg
5.33%
3Y Avg
-0.33%
5Y Avg
-1.99%
Market Cap
$40.97B
Operating Margin
32.03%
TTM Avg
30.27%
3Y Avg
29.30%
5Y Avg
28.64%
Market Cap
$40.75B
Operating Margin
22.23%
TTM Avg
22.07%
3Y Avg
21.88%
5Y Avg
20.79%
Market Cap
$49.78B
Operating Margin
9.83%
TTM Avg
11.84%
3Y Avg
11.67%
5Y Avg
10.68%
Market Cap
$49.91B
Operating Margin
28.09%
TTM Avg
26.16%
3Y Avg
28.11%
5Y Avg
28.79%
Market Cap
$34.15B
Operating Margin
20.81%
TTM Avg
2.82%
3Y Avg
-21.37%
5Y Avg
-56.25%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | $42.12B | 13.57% | 13.36% | 13.39% | 13.19% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.07B | 11.45% | 5.33% | -0.33% | -1.99% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.97B | 32.03% | 30.27% | 29.30% | 28.64% |
| Agilent Technologies, Inc. (A)vs › | $40.75B | 22.23% | 22.07% | 21.88% | 20.79% |
| Humana Inc. (HUM)vs › | $47.18B | 1.39% | 1.25% | 2.37% | 3.27% |
| Becton, Dickinson and Company (BDX)vs › | $49.78B | 9.83% | 11.84% | 11.67% | 10.68% |
| Edwards Lifesciences Corporation (EW)vs › | $49.91B | 28.09% | 26.16% | 28.11% | 28.79% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.15B | 20.81% | 2.82% | -21.37% | -56.25% |
| Alcon Inc. (ALC)vs › | $33.72B | 9.87% | 13.67% | 11.51% | 7.66% |
| ResMed Inc. (RMD)vs › | $31.90B | 33.48% | 33.11% | 30.30% | 29.57% |
Gross Margin
26.2%
Operating Margin
13.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 11.58% |
| 2026-03-31 | 12.38% |
| 2025-12-31 | 16.77% |
| 2025-09-30 | 13.49% |
| 2025-06-30 | 12.60% |
| 2025-03-31 | 12.95% |
| 2024-12-31 | 15.82% |
| 2024-09-30 | 14.12% |
| 2024-06-30 | 14.37% |
| 2024-03-31 | 13.54% |
| 2023-12-31 | 12.95% |
| 2023-09-30 | 12.87% |
| 2023-06-30 | 14.06% |
| 2023-03-31 | 12.90% |
| 2022-12-31 | 10.14% |
| 2022-09-30 | 13.25% |
| 2022-06-30 | 13.18% |
| 2022-03-31 | 13.87% |
| 2021-12-31 | 12.87% |
| 2021-09-30 | 8.91% |
| 2021-06-30 | 8.38% |
| 2021-03-31 | 10.03% |
| 2020-12-31 | 8.76% |
| 2020-09-30 | 6.71% |
| 2020-06-30 | 3.21% |
| 2020-03-31 | 7.01% |
| 2019-12-31 | 5.73% |
| 2019-09-30 | 8.12% |
| 2019-06-30 | 7.19% |
| 2019-03-31 | 7.82% |
| 2018-12-31 | 7.70% |
| 2018-09-30 | 6.98% |
| 2018-06-30 | 6.62% |
| 2018-03-31 | 7.14% |
| 2017-12-31 | 7.88% |
| 2017-09-30 | 7.99% |
| 2017-06-30 | 6.41% |
| 2017-03-31 | 7.12% |
| 2016-12-31 | 6.16% |
| 2016-09-30 | 11.21% |
| 2016-06-30 | 9.71% |
| 2016-03-31 | 12.00% |
| 2015-12-31 | 11.70% |
| 2015-09-30 | 11.72% |
| 2015-06-30 | 10.97% |
| 2015-03-31 | 10.63% |
| 2014-12-31 | 11.26% |
| 2014-09-30 | 10.65% |
| 2014-06-30 | 10.51% |
| 2014-03-31 | 10.81% |
| 2013-12-31 | 9.21% |
| 2013-09-30 | 10.47% |
| 2013-06-30 | 7.32% |
| 2013-03-31 | 9.37% |
| 2012-12-31 | 7.39% |
| 2012-09-30 | 9.10% |
| 2012-06-30 | 8.20% |
| 2012-03-31 | 7.95% |
